Cyted Health
Last verified 2026-05-19. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $100.0Mattributed |
|---|---|
| Latest round | series-b, $44.0M, 2025-09-01attributed |
| Founded | 2018 |
| Headquarters | Cambridge |
| Industry | bio |
| Stage | series-b+ |
| Website | cyted.health |
Cyted Health pairs a swallowable sponge-on-a-string cell collector with AI and molecular biomarkers for early cancer signs. It serves clinicians screening chronic-reflux patients for Barrett's esophagus. Its EndoSign test detects ten times as many cases as standard care, reaching 30,000 UK patients.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-09-01 | series-b | $44.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series B, $44.0M | attributed | sifted named as publisher. No document URL on file. |
| Total raised $100.0M | attributed | sifted named as publisher. No document URL on file. |
| Company existence | self-reported | cyted.health, read 2026-05-19 |
| Description | self-reported | cyted.health, read 2026-05-19 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.